rs1898830

Variant summary

Our verdict is Likely benign.
-4 Likely Benign
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received -4 classification points (ACGS-UK Somatic Oncogenicity v2025). B1_Strong

The NM_001318789.2(TLR2):c.-162-601A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The gene TLR2 is a tumor suppressor gene (CancerMine: 2 TSG, 4 oncogene, 1 driver citations). The gene TLR2 is a known oncogene (CancerMine: 2 TSG, 4 oncogene, 1 driver citations). The gene TLR2 is a cancer driver gene (CancerMine: 2 TSG, 4 oncogene, 1 driver citations). The variant allele was found at a cumulative frequency of 0.308 (AC=46,871) in the gnomAD database across 152,062 control chromosomes, including 8,193 homozygotes. The grpmax filtering allele frequency (95% CI) is 0.522. In-silico predictor (BayesDel (noAF)) classifies this variant as likely benign. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.31 ( 8193 hom., cov: 32)

Consequence

TLR2
NM_001318789.2 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.320

Publications

4 publications found
Variant links:
Genes affected
TLR2 (HGNC:11848): (toll like receptor 2) The protein encoded by this gene is a member of the Toll-like receptor (TLR) family which plays a fundamental role in pathogen recognition and activation of innate immunity. TLRs are highly conserved from Drosophila to humans and share structural and functional similarities. This protein is a cell-surface protein that can form heterodimers with other TLR family members to recognize conserved molecules derived from microorganisms known as pathogen-associated molecular patterns (PAMPs). Activation of TLRs by PAMPs leads to an up-regulation of signaling pathways to modulate the host's inflammatory response. This gene is also thought to promote apoptosis in response to bacterial lipoproteins. This gene has been implicated in the pathogenesis of several autoimmune diseases. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2016]

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_001318789.2, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACGS-UK Somatic Oncogenicity v2025

Classification was made for transcript:

Our verdict: Likely_benign. The variant received -4 points.

B1High frequency in general population
GnomAD effective popmax AF >1% — B1 stand-alone benign; GnomAD effective popmax AF = 0.522 — exceeds 1% threshold (B1 applied)

Variant Effect in Transcripts

Automated classification analysis was done for transcript: NM_001318789.2. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

TLR2 NM_001318789.2
MANE Select
HGVSc / HGVSpc.-162-601A>G
Exon rankIntron 1 of 2
intron
Prot: NP_001305718.1UniProt: O60603A0A0S2Z4S4
TLR2 NM_001318787.2
HGVSc / HGVSpc.-372-616A>G
Exon rankIntron 1 of 3
intron
Prot: NP_001305716.1UniProt: A0A0S2Z4S4O60603
TLR2 NM_001318790.2
HGVSc / HGVSpc.-162-601A>G
Exon rankIntron 1 of 2
intron
Prot: NP_001305719.1UniProt: O60603A0A0S2Z4S4

Ensembl Transcripts

TLR2 ENST00000642700.2
MANE Select
HGVSc / HGVSpc.-162-601A>G
Exon rankIntron 1 of 2
intron
Prot: ENSP00000494425.1UniProt: O60603
TLR2 ENST00000260010.7
TSL:6
HGVSc / HGVSpc.-1554-601A>G
Exon rankIntron 1 of 2
intron
Prot: ENSP00000260010.6UniProt: O60603
TLR2 ENST00000642580.1
HGVSc / HGVSpc.-88-616A>G
Exon rankIntron 1 of 2
intron
Prot: ENSP00000495339.1UniProt: O60603

Frequencies

Allele frequencies (AF), counts (AC/AN), homozygotes and coverage

Common (AF > 0.05 / Hom > 5)
Rare (AF ≤ 0.0001 / Hom ≤ 1)
Global population databases 4 sources
GnomAD3 genomes
AF: 0.308
AC:46841
Hom:8176
AN:151942
Cov:32
GnomAD4 genome
AF: 0.308
AC:46871
Hom:8193
AN:152062
Cov:32
TOPMed (Bravo)
AF: 0.307
AC:81240
Hom:14593
AN:264690
ALFA (dbGaP/dbSNP Allele Frequency Aggregator)
AF: 0.325
AC:28081
Hom:4993
AN:86508
Local & regional cohorts 10 sources
ABraOM SABE-WGS-1171
AF: 0.322
AC:755
Hom:114
AN:2342
ChinaMAP Phase 1
AF: 0.425
Denmark Genome
AF: 0.377
AC:113
AN:300
GenomeAsia100K
AF: 0.477
AC:1650
AN:3460
Korea4K (4,157 Koreans)
AF: 0.447
AC:3225
AN:7218
Qatari Genome
AF: 0.239
AC:42
AN:176
ToMMo 61KJPN (+60KJPN MNV)
AF: 0.455
AC:55730
Hom:12739
AN:122508
Turkish Variome
AF: 0.422
AC:652
Hom:136
AN:1546
UK10K
AF: 0.345
AC:2612
AN:7562
WBBC (Westlake BioBank for Chinese) pilot
AF: 0.427
AC:3824
Hom:816
AN:8960
Showing 14 sources

ClinVar

Not reported in ClinVar

Computational Scores

AlphaGenome AVI
Benign4.9
BayesDel_noAF
Benign-0.68
CADD
Benign4.5
DANN
Benign0.89
GPN-Star LLR
N/A-0.55
GPN-Star score
N/A0.55
PhyloP100
Benign-0.32
Showing 7 of 7 scores

Splicing Scores

Pangolin (max)
Benign0.0
Showing 1 of 1 scores

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

MaveDB functional evidence

MaveDB is a public repository of laboratory assays that test the effect of thousands of variants at once — treat this as supporting research data and interpret it with great caution; it is not a clinical classification.

No MaveDB functional evidence found for this variant.

Publications

Other links and lift over

For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.